Search results for "Endovascular Procedure"

showing 10 items of 131 documents

Mid-term results of zone 0 thoracic endovascular aneurysm repair after ascending aorta wrapping and supra-aortic debranching in high-risk patients

2017

Objectives Surgical repair of aneurysmal disease involving the ascending aorta, aortic arch and eventually the descending aorta is generally associated with significant morbidity and mortality. A less invasive approach with the ascending wrapping technique (WT), supra-aortic vessel debranching (SADB) and thoracic endovascular aneurysm repair (TEVAR) in zone 0 was developed to reduce the associated risk in these patients. Methods During a 10-year period, consecutive patients treated by the ascending WT, SADB and TEVAR in zone 0 were included. All patients were considered at high risk for conventional surgery. Measured outcomes included perioperative deaths and morbidity, maximal aortic trans…

MaleAortic archTime FactorsComputed Tomography AngiographyAneurysm; Arch; Ascending; Debranching; TEVAR; Wrapping; Surgery; Pulmonary and Respiratory Medicine; Cardiology and Cardiovascular Medicinemedicine.medical_treatmentWrapping030204 cardiovascular system & hematologyEndovascular aneurysm repairPostoperative Complications0302 clinical medicineRisk FactorsAscendingThoracic aorta030212 general & internal medicineAortaAged 80 and overTEVAR10042 Clinic for Diagnostic and Interventional RadiologyEndovascular ProceduresMiddle Aged2746 SurgeryItalyDescending aortaCardiologyFemaleCardiology and Cardiovascular MedicinePulmonary and Respiratory Medicinemedicine.medical_specialty10216 Institute of Anesthesiology610 Medicine & healthArch2705 Cardiology and Cardiovascular Medicine03 medical and health sciencesAneurysmBlood vessel prosthesismedicine.arteryInternal medicineAscending aortamedicineHumansAgedAortaAortic Aneurysm Thoracicbusiness.industryDebranchingmedicine.diseaseAneurysmBlood Vessel ProsthesisSurgery10020 Clinic for Cardiac Surgery2740 Pulmonary and Respiratory MedicineSurgeryMorbiditybusinessFollow-Up Studies
researchProduct

Endovascular treatment of large and wide aortic neck: case report and literature review

2017

Large (24–34 mm) and wide (≥35 mm) aortic necks are a contraindication to endovascular aneurysm repair (EVAR). A 63-year-old man, unfit for conventional surgery, presented a 79 mm abdominal aortic aneurysm with 36.5 mm aortic neck and a 62 mm right common iliac artery aneurysm. He was treated endovascularly with standard commercially available stent-graft using the so-called ‘funnel technique’; by placing a thoracic stent-graft inside a bifurcated device to achieve proximal sealing. The completion angiography and the 6 months follow-up with computed tomography showed no stent-graft migration, limb occlusion or endoleak. The literature review reported 179 cases of large aortic neck managed w…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorsEndoleakTime Factormedicine.medical_treatmentRight Common Iliac Artery030204 cardiovascular system & hematologyEndovascular aneurysm repairSettore MED/22 - Chirurgia Vascolare030218 nuclear medicine & medical imaging03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicineAneurysmOcclusionmedicineStentHumanscardiovascular diseasesComplications; Endoleak; Funnel technique; Large neck; Migration; Aortic Aneurysm Abdominal; Blood Vessel Prosthesis Implantation; Endovascular Procedures; Humans; Male; Middle Aged; Time Factors; Tomography X-Ray Computed; Stents; Surgery; Pulmonary and Respiratory Medicine; Cardiology and Cardiovascular MedicineContraindicationMigrationEndovascular Proceduremedicine.diagnostic_testLarge neckbusiness.industryEndovascular ProceduresGeneral MedicineMiddle Agedmedicine.diseaseAbdominal aortic aneurysmSurgerysurgical procedures operativeAngiographycardiovascular systemStentsSurgeryAortic neckbusinessFunnel techniqueTomography X-Ray ComputedCardiology and Cardiovascular MedicineComplicationAortic Aneurysm AbdominalHuman
researchProduct

Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020

2020

Over the last years, the endovascular approach to the management of the acute and chronic deep vein thrombosis (DVT) has gained more and more attention from the scientific community. DVT is the third most common cardiovascular disease after coronary heart disease and stroke, with classic treatment based on anticoagulation. Recent evidences have highlighted the risk of postthrombotic syndrome as high as 30%-50% in proximal ilio-femoral lesions, with irreversible clinical symptoms and impact on the quality of life of the population. Since 2000s, the new concept of thrombus removal in the acute phase has been supported by the introduction of different techniques based on the endovascular ablat…

medicine.medical_specialty[SDV]Life Sciences [q-bio]medicine.medical_treatmentDeep veinPopulationDiseaseIliac Vein030204 cardiovascular system & hematologyPostthrombotic Syndrome03 medical and health sciences0302 clinical medicineFibrinolysismedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineThrombusIntensive care medicineeducationStrokeComputingMilieux_MISCELLANEOUSVenous Thrombosiseducation.field_of_studybusiness.industryEndovascular ProceduresGeneral Medicinemedicine.diseaseThrombosis3. Good healthVenous thrombosisTreatment Outcomemedicine.anatomical_structureQuality of LifeCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Interventions
researchProduct

Contemporary spinal cord protection during thoracic and thoracoabdominal aortic surgery and endovascular aortic repair: a position paper of the vascu…

2015

Ischaemic spinal cord injury (SCI) remains the Achilles heel of open and endovascular descending thoracic and thoracoabdominal repair. Neurological outcomes have improved coincidentially with the introduction of neuroprotective measures. However, SCI (paraplegia and paraparesis) remains the most devastating complication. The aim of this position paper is to provide physicians with broad information regarding spinal cord blood supply, to share strategies for shortening intraprocedural spinal cord ischaemia and to increase spinal cord tolerance to transitory ischaemia through detection of ischaemia and augmentation of spinal cord blood perfusion. This study is meant to support physicians cari…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyHeelIntraoperative Neurophysiological MonitoringIschemiaThoracic Surgical ProcedureAorta Thoracic610 Medicine & healthSpinal cord injuryThoracic aorta142-005 142-0052705 Cardiology and Cardiovascular Medicinemedicine.arterymedicineThoracic aortaHumansAorta Abdominal610 Medicine & healthSpinal cord injuryEndovascular ProcedureAortic Aneurysm ThoracicTEVARbusiness.industrySpinal Cord IschemiaEndovascular ProceduresThoracoabdominal aortaGeneral MedicineThoracic Surgical Proceduresmedicine.diseaseSpinal cordSurgery2746 SurgeryEuropemedicine.anatomical_structureSpinal CordCardiothoracic surgery2740 Pulmonary and Respiratory MedicineAnesthesiaPractice Guidelines as TopicSurgeryParaplegiaComplicationbusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Optimizing endovascular stroke treatment: removing the microcatheter before clot retrieval with stent-retrievers increases aspiration flow

2016

BackgroundFlow control during endovascular stroke treatment with stent-retrievers is crucial for successful revascularization. The standard technique recommended by stent-retriever manufacturers implies obstruction of the respective access catheter by the microcatheter, through which the stent-retriever is delivered. This, in turn, results in reduced aspiration during thrombectomy. In order to maximize aspiration, we fully retract the microcatheter out of the access catheter before thrombectomy—an approach we term the ‘bare wire thrombectomy’ (BWT) technique. We verified the improved throughput with systematic in vitro studies and assessed the clinical effectiveness and safety of this metho…

AdultMalemedicine.medical_specialtyCathetersAdolescentmedicine.medical_treatmentRevascularizationBalloon030218 nuclear medicine & medical imagingYoung Adult03 medical and health sciences0302 clinical medicinemedicineHumansProspective StudiesChildStrokeAgedRetrospective StudiesThrombectomyStent retrieverAged 80 and overbusiness.industryEndovascular ProceduresStentGeneral MedicineMiddle Agedmedicine.diseaseStandard techniqueSurgeryStrokeStroke treatmentCatheterTreatment OutcomeFemaleStentsSurgeryNeurology (clinical)Radiologybusiness030217 neurology & neurosurgeryJournal of NeuroInterventional Surgery
researchProduct

Anticoagulation with argatroban for elective percutaneous coronary intervention: population pharmacokinetics and pharmacokinetic-pharmacodynamic rela…

2010

The synthetic direct thrombin inhibitor argatroban has a rapid onset and offset of anticoagulation. However, there are no data about the pharmacokinetic-pharmacodynamic (PK-PD) relationship of argatroban in patients undergoing contemporary percutaneous coronary intervention (PCI) and no data about other coagulation parameters than activated clotting time (ACT) in this setting. In the ARG-E04-trial, 140 patients were randomly assigned to argatroban (250, 300, or 350 μg/kg as bolus before PCI, followed by 15, 20, or 25 μg/kg/min infusion) or unfractionated heparin (70-100 IU/kg bolus). A 2-compartment model with first-order elimination adequately described the pharmacokinetic profile of argat…

Malemedicine.medical_treatmentActivated clotting timeArginineArgatrobanAntithrombinsBolus (medicine)PharmacokineticsmedicineHumansPharmacology (medical)Blood CoagulationAgedPharmacologySulfonamidesModels Statisticalmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryHeparinEndovascular ProceduresPercutaneous coronary interventionHeparinMiddle AgedClotting timeDirect thrombin inhibitorAnesthesiaPipecolic AcidsFemaleBlood Coagulation Testsbusinessmedicine.drugJournal of clinical pharmacology
researchProduct

Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.

2023

Background and ObjectivesCOVID-19–related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.MethodsThis was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regress…

Fibrinolytic Agents/therapeutic useCerebral Hemorrhage/complicationsStroke/epidemiologyBrain Ischemia/complicationsTreatment OutcomeIschemic Stroke/epidemiologyCOVID-19/complicationsHumansCohort studiesEndovascular Procedures/adverse effectsRegistriesNeurology (clinical)610 Medicine & healthIntracranial Hemorrhages/etiologyThrombolytic Therapy/adverse effectsResearch Article
researchProduct

Popliteal Artery Aneurysm Repair in the Endovascular Era: Fourteen-Years Single Center Experience

2015

Abstract To compare outcomes of popliteal artery aneurysm (PAA) repair by endovascular treatment, great saphenous vein (GSV) bypass, and prosthetic bypass. Single center retrospective analysis of patients presenting PAA from 2000 to 2013. Patients were divided into endovascular treatment (group A); GSV bypass (group B); and prosthetic graft bypass (group C). Outcomes were technical success, perioperative mortality, and morbidity. Survival, primary and secondary patency, and freedom from reintervention rate were estimated. Differences in ankle-brachial index (ABI), in-hospital length of stay (InH-Los), red blood cell (RBC) transfusion, and limb loss were reported. Mean follow-up was 49 (medi…

Malemedicine.medical_specialtyTime Factors7100Observational Study610 Medicine & health2700 General MedicineSingle CenterSettore MED/22 - Chirurgia VascolareGroup Blaw.inventionBlood Vessel Prosthesis ImplantationAneurysmRandomized controlled triallawmedicine.arteryPopliteal Artery AneurysmmedicineHumansPopliteal ArteryAgedRetrospective Studiesbusiness.industryGreat saphenous veinEndovascular ProceduresAngiographyRetrospective cohort studyGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseAneurysmPopliteal artery10020 Clinic for Cardiac SurgerySurgeryTreatment OutcomeSurgery Computer-AssistedAnesthesiaFluoroscopyFemaleStentsbusinessFollow-Up StudiesForecastingResearch Article
researchProduct

Cinical outcomes of Endurant II stent-graft for infrarenal aortic aneurysm repair: comparison of on-label versus off-label use.

2016

Purpose We aimed to compare the outcomes of the Endurant II (Medtronic) stent-graft used under instructions for use versus off-label in high-risk patients considered unfit for conventional surgery. Methods Data from patients treated with the Endurant II stent-graft between December 2012 and March 2015 were retrospectively analyzed. Sixty-four patients were included. Patients were assigned to group A if treated under instructions for use (n=34, 53%) and to group B if treated off-label (n=30, 47%). Outcome measures included perioperative mortality and morbidity, survival, freedom from reintervention, endoleak incidence, in-hospital length of stay, and mean stent-graft component used. Mean fol…

Malemedicine.medical_specialtyEndoleakmedicine.medical_treatment030204 cardiovascular system & hematologyProsthesis DesignSettore MED/22 - Chirurgia VascolareRisk AssessmentGroup B03 medical and health sciencesAortic aneurysm0302 clinical medicinePostoperative ComplicationsOcclusionInterventional RadiologyMedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineSurvival analysisAgedAged 80 and overbusiness.industryRadiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular MedicineEndovascular ProceduresStentPerioperativeOff-Label UseMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryBlood Vessel ProsthesisTreatment OutcomeFemaleStentsCardiology and Cardiovascular MedicinebusinessComplicationAbdominal surgeryAortic Aneurysm AbdominalDiagnostic and interventional radiology (Ankara, Turkey)
researchProduct

Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

2010

Objectives The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI). Although balloon angioplasty and stenting seem to be safe procedures, there are currently no data on the treatment of a large group of patients with this vascular pathology. Methods A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) were performed during 344 interventions in 331 CCSVI patients with associated multiple sclerosis. Results Balloon angioplasty alone was performed in 192 cases (55.8%), whereas the stenting of at least one vein was required in the remaining 152 cases (44.2%). There were no majo…

endovascular treatmentAdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentmedicine.medical_treatmentFemoral veinBalloonYoung AdultPostoperative ComplicationsCentral Nervous System DiseasesAngioplastymedicineHumansVeinAgedbusiness.industryEndovascular ProceduresStentPhlebographyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryVenous thrombosisChronic cerebrospinal venous insufficiencymedicine.anatomical_structureVenous InsufficiencyChronic DiseaseFemaleStentsRadiologyCardiology and Cardiovascular MedicineVenous malformationbusinessvenous malformationAngioplasty BalloonMagnetic Resonance AngiographyPhlebology: The Journal of Venous Disease
researchProduct